Skip to main content
O

OK BIOTECH CO., LTD. — Investor Relations & Filings

Ticker · 4155 TW Manufacturing
Filings indexed 1,709 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country TW Taiwan
Listing TW 4155

About OK BIOTECH CO., LTD.

http://www.okbiotech.com

OK Biotech Co., Ltd. is a medical device company specializing in the research, development, manufacturing, and global distribution of diagnostic and home healthcare solutions. Established in 2004, the company focuses on blood glucose monitoring systems, including high-precision meters and test strips, alongside over-the-counter (OTC) hearing aids and multiple frequency therapy devices. OK Biotech provides comprehensive services ranging from product design to complete factory setup solutions, supporting partners from initial planning through to mass production. By leveraging advanced R&D and production technologies, the company delivers reliable OEM and ODM solutions designed for both personal wellness and professional clinical applications. Its commitment to technical innovation ensures the delivery of high-quality medical instruments and tailored healthcare support to a global market.

Recent filings

Filing Released Lang Actions
公告本公司115年第一季財務報告董事會召開日期
Regulatory Filings
2026-05-04 Chinese
115年年報及股東會資料 — 2026_4155_20260602F13.pdf
AGM Information Classification · 1% confidence The document is the reference materials and agenda items for the company’s Annual General Meeting (股東常會), listing all proposals, reports, approvals, and discussion items to be presented at the meeting. This aligns with AGM Information (AGM-R).
2026-04-29 Chinese
115年年報及股東會資料 — 2026_4155_20260602FE2.pdf
Regulatory Filings
2026-04-29 Chinese
115年年報及股東會資料 — 2026_4155_20260602F02.pdf
Regulatory Filings
2026-04-29 Chinese
115年年報及股東會資料 — 2026_4155_20260602F01.pdf
Regulatory Filings
2026-04-29 Chinese
115年年報及股東會資料 — 2026_4155_20260602FE1.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a notice to shareholders announcing the regular shareholders’ meeting, detailing the agenda, dividend distribution, proxy voting instructions, and electronic voting procedures. It is providing materials to solicit votes and inform shareholders in advance of the meeting. This matches the definition of “Proxy Solicitation & Information Statement (PSI).”
2026-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.